Arrowstreet Capital, Limited Partnership Takeda Pharmaceutical CO LTD Call Options Transaction History
Arrowstreet Capital, Limited Partnership
- $122 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TAK
# of Institutions
338Shares Held
68.6MCall Options Held
1.72MPut Options Held
178K-
Capital Research Global Investors Los Angeles, CA13.2MShares$183 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.6MShares$77.9 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.63MShares$64.3 Million0.01% of portfolio
-
First Trust Advisors LP Wheaton, IL3.24MShares$45 Million0.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.08MShares$42.8 Million0.06% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $43.2B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...